Sri Lanka: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)   |   CE2021-0010

Contact:

Office of Agricultural Affairs, Colombo   |   (011-94) (11) 249-8500

Sri Lanka does not produce genetically engineered (GE) crops or animals. Some GE research, however, occurs at the laboratory level, but that research does not reach commercialization. The lack of a legal framework and proper biosafety procedures are a major setback. The country is in the process of developing regulatory biotechnology policies. Policies, however, remain at varying stages of development and implementation. Policies include the National Biotechnology Policy, the National Biosafety Framework (that includes the National Biosafety Policy and National Biosafety Act), as well as the Control of Import, Labeling and Sale of Genetically Modified Foods Regulation of 2006. Development of the National Biosafety Framework conforms to the country’s commitments under the Cartagena Protocol (signed and ratified in 2004). The new legal framework for biosafety will become effective with the enactment of the National Biosafety Act, but that has been undergoing review for several years.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.